Richard Jacroux
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Richard Jacroux
Richard Jacroux is recorded as CFO at ENDRA Life Sciences Inc. (NDRA). ENDRA Life Sciences Inc. reported in an 8-K filed August 13, 2024 that Richard Jacroux was appointed Chief Financial Officer. The proxy statement of ENDRA Life Sciences Inc. reports total compensation of $95,900 for Richard Jacroux in fiscal 2024, including a base salary of $95,900. Richard Jacroux has spoken on 1 earnings call across 1 company, most recently for ENDRA Life Sciences Inc. on August 23, 2024.
“The Company also announced the addition to its senior management team of Ziad Rouag as Head of Regulatory and Clinical Affairs and Richard Jacroux as Chief Financial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at ENDRA Life Sciences Inc.
Other people whose current roles at this company are on record from its filings.
- Alexander Tokman CEO, Chairman, Board Member
- Anthony DiGiandomenico Board Member
- Louis J. Basenese Board Member
- Michael Harsh Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | ENDRA Life Sciences Inc. (NDRA) | Chief Financial Officer (since August 8, 2024) | $95,900 | $95,900 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.